Browse articles from EyeWorld.org related to SLT. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
The DSLT laser (Voyager, Alcon) became commercially available in the U.S. earlier this year, and many surgeons are beginning to incorporate this into their glaucoma treatment paradigm. Several physicians discussed this new technology, how it compares to SLT, and how they’re using it in their practices.
SLT has gained popularity in the treatment of glaucoma, and there are several new laser technologies and procedures in various stages of development. Glaucoma specialists spoke with EyeWorld about a few of the newer options and what they’re excited about.
In some glaucoma practices, selective laser trabeculoplasty (SLT) has become a mainstay option at various stages of disease and treatment. However, some ophthalmologists say that despite its diverse utility, SLT adoption has been slow in other practices, and a more recent advancement in related technology could increase adoption.
Where do drops fit in the era of interventional glaucoma—a time when there are new technologies, new drug delivery systems, and several MIGS options?
Get the latest ophthalmology news delivered to your inbox every Friday.